The parallel session at Norway Life Science 2024, hosted by dScience on Tuesday, February 13th, drew an engaged audience who actively participated by posing a number of questions to the speakers.
The main takeaway points are that artificial intelligence (AI) significantly enhances life sciences through improved diagnostics, personalised medicine, and accelerated drug discovery, while also emphasising the need for ethical considerations, data privacy, and interdisciplinary collaboration.